Results 101 to 110 of about 936,523 (298)

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich   +19 more
wiley   +1 more source

Serum tumour marker (CEA, CA 19-9 and CA 27-29) levels and their association with clinicopathological parameters in Nigerian breast cancer patients

open access: yesMedical Research Journal
INTRODUCTION: To hasten management and improve patients’ quality of life, there is a need for quick, cheap and accessible biomarkers of breast cancer prognosis following confirmatory diagnosis.
Ganiyu Olatunbosun Arinola   +3 more
doaj   +1 more source

Serial levels of CA 19-9 and CEA in colonic cancer.

open access: yes, 1986
The use of serial carbohydrate antigen (CA) 19-9 assays was assessed by comparison with serial carcino-embryonic antigen (CEA) levels on the plasmas of 53 patients with colorectal carcinoma.
P T Lavin   +7 more
core   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos   +9 more
wiley   +1 more source

CA 19-9: handle with care [PDF]

open access: yes, 2013
Since its inception in the mid-1980s of the 20th century testing for carbohydrate antigen 19-9 (CA 19-9) has raised expectation for an earlier diagnosis and accurate monitoring of several malignant diseases. After almost 30 years, the available evidences
PLEBANI, MARIO, Galli C, BASSO, DANIELA
core   +1 more source

Diagnostic Use of Testing for Novel Murine Autoantibodies for Sjögren Disease in the Rheumatology Outpatient Setting

open access: yesArthritis Care &Research, EarlyView.
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr   +5 more
wiley   +1 more source

Comparison between serum CA 125 and CA 19-9 assays and tissular OC 125 and 1116NS 19-9 reactivity in malignant and benign ovarian tumors

open access: yes, 1992
This preliminary study included 25 patients with primary epithelial ovarian cancer (EOC) (18 serous, 3 serous-mucinous, 1 endometrioid, 2 undifferentiated carcinomas and 1 malignant Brenner carcinoma); 2 patients with borderline ovarian tumors and 20 ...
F. De Luca   +8 more
core  

The Relation between CA 19-9 level and Early-Phase Insulin Secretion in Normoglycemic and Prediabetic Subjects

open access: yesThe International Journal of Biological Markers, 2015
Background Carbohydrate antigen (CA) 19-9 is used as a clinical tumor marker of pancreatic cancer; recent studies report that CA 19-9 is also associated with changes in blood glucose levels.
Masanori Shimodaira MD, PhD   +5 more
doaj   +1 more source

[Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].

open access: yesWiadomosci lekarskie (Warsaw, Poland : 1960), 2004
Difficulties in differentiation between inflammatory and neoplastic tumors of pancreas cause that the diagnostics based on image examinations requires the assessment of neoplastic markers. The aim of the paper is to evaluate the usefulness of Ca 19-9 in differentiation of inflammatory and neoplastic pancreatic tumors. Examinations were carried out on a
openaire   +1 more source

Strain‐Programmable Luminescent Adhesive Patch With Tartrazine‐Mediated Optical Skin Clearing for Photochemical Tissue Bonding

open access: yesAdvanced Functional Materials, EarlyView.
We propose a suture‐complementary approach that integrates optical skin clearing with a strain‐programmable luminescent adhesive patch. Hyaluronic acid promotes transdermal delivery of tartrazine to improve optical clearing and stabilizes its interaction with a photosensitizer. Optical clearing increases the penetration depth of visible light into skin,
Seong‐Jong Kim   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy